Learn about Amyotrophic Lateral Sclerosis (ALS), its symptoms, risk factors, diagnosis, and current research advancements.

The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in ...

Itvisma contains the active ingredient in Zolgensma approved in 2019 for children younger than 2 years but is reformulated ...

Novartis wins FDA approval for Itvisma, a one-time gene therapy offering broader SMA treatment with sustained motor function ...

Researchers in Australia have identified a three-drug combination that greatly extends the survival of motor neuron cells in ...

Sinfield revealed this year's ultramarathon challenge - taking in more than 50km (31 miles) each day - would take place in ...

Late-breaking oral presentation by a leading global authority in Dementia with Lewy bodies (DLB) to highlight updated data from Phase 2b study on ...

The experimental therapy M102 slowed disease progression in preclinical experiments done in mouse and cell models of ALS, a ...

The Prince of Wales met Burrow’s children, his wife Lindsey, and his rugby team-mate Kevin Sinfield when he opened the new MND centre in Leeds.

On Thursday, Nov. 20, Prince William headed to Leeds in the north of England for an emotional reunion with the widow of rugby ...

M107 is the first potential disease-modifying drug for the treatment of gastroparesis -- M107's mechanism of action has been shown to shift pro-inflammatory M1 macrophages towards M2 anti-inflammatory ...